Premier Biomedical, Inc. (BIEI)
Market Cap | 539.50K |
Revenue (ttm) | 14.28K |
Net Income (ttm) | -374.47K |
Shares Out | 1.20B |
EPS (ttm) | -0.01 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 240,600 |
Average Volume | 5,917,774 |
Open | 0.0004 |
Previous Close | 0.0004 |
Day's Range | 0.0004 - 0.0005 |
52-Week Range | 0.0004 - 0.0021 |
Beta | -0.22 |
RSI | 41.10 |
Earnings Date | n/a |
About Premier Biomedical
Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil ca... [Read more]
Full Company ProfileFinancial Performance
In 2019, Premier Biomedical's revenue was $14,281, a decrease of -64.11% compared to the previous year's $39,795. Losses were -$374,470, -6.12% less than in 2018.
Financial StatementsNews

Premier Graphene Showcases Hemp Graphene for Military Use
Enhancing Military Protection: Advanced Proprietary Gear Engineered for Maximum Defense Across All Branches Key Points: Cutting-Edge Green Graphene for Defense & Security Premier Graphene Inc. (OTC: B...

BIEI: Premier Graphene and its Mexico Affiliate Invited by Mexico's Armed Forces and Security Forces to Present Protective Products Developed, Including from Contributions of their Affiliates
EL CENTRO, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Premier Graphene Inc. (OTC: BIEI), announced today Premier Graphene Inc.'s monumental progress from President Pedro Mendez' efforts securing the ap...

Premier Graphene Completes Joint Venture with Leading Technology and Systems Development Company Isatek S.A. de C.V.
EL CENTRO, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Premier Graphene Inc. (OTC PINK: BIEI), formerly Premier Biomedical Inc., announced today the completion of a joint venture between publicly traded...

Premier Graphene's Proprietary Graphene-Modified Asphalt Demonstrates Substantial Stability and Performance Improvements Compared to Conventional Asphalt in Laboratory Tests
EL CENTRO, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Premier Graphene Inc. (OTC: BIEI), formerly Premier Biomedical Inc., announced today a groundbreaking technical report with significant implication...

Premier Graphene, Inc. Ships Advanced Graphene Suspension Samples to Global Leader in Essential Materials
EL CENTRO, Calif., July 08, 2024 (GLOBE NEWSWIRE) -- Premier Graphene, Inc. (OTC PINK: BIEI) announced today that it shipped HGI's proprietary graphene suspension test samples to one of the largest es...

Premier Biomedical Inc. (OTC PINK: BIEI), now known as Nova-Graphene Ballistics, Inc., Announces Agreements to Manufacture its Revolutionary 3D-Printed Ballistic Armor Using its Proprietary Graphene Production Methodology
Premier, N/K/A Nova-Graphene Ballistics, Inc., has Acquired the Rights to Use, Within the United States, this Proprietary Technology for Lightweight, Extremely Protective, Graphene Ballistic Plate Pro...